Stay updated on Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial

Sign up to get notified when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a minor page metadata update rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-05T11:53:54.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now displays revision: v3.5.4, replacing v3.5.3. This reflects a small, metadata-level update to the study record on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-05-14T23:14:17.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    No textual changes are present in the provided data for this page; the content shown remains unchanged relative to the source.
    Difference
    0.1%
    Check dated 2026-05-07T21:59:57.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.3, replacing the previous Revision: v3.5.2, indicating a new document revision.
    Difference
    0.1%
    Check dated 2026-04-30T16:31:20.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:16:12.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-25T20:15:01.000Z thumbnail image

Stay in the know with updates to Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.